GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 4,440.00
-380.00 (-7.88%)
At close: May 29, 2026
GC Medical Science Market Cap
GC Medical Science has a market cap or net worth of 96.53 billion as of May 29, 2026. Its market cap has increased by 16.57% in one year.
Market Cap
96.53B
Enterprise Value
117.08B
Revenue
105.48B
Ranking
n/a
PE Ratio
36.00
Stock Price
4,440.00
Market Cap Chart
Since December 17, 2014, GC Medical Science's market cap has decreased from 98.95B to 96.53B, a decrease of -2.44%. That is a compound annual growth rate of -0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 96.53B | 10.86% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 295.29B |
| 3billion | 280.45B |
| GENINUS | 116.89B |
| Inventera | 110.67B |
| Cytogen | 98.16B |
| HLB Panagene | 66.66B |
| Protia | 54.99B |
| Seoulin Bioscience | 50.16B |